Posted in | Nanomedicine

Arrowhead Research CEO to Discuss Company’s Focus on Nanomedicine

Arrowhead Research Corporation (NASDAQ: ARWR) today announced that Dr. Christopher Anzalone, Chief Executive Officer, will be presenting at the Rodman & Renshaw Annual Global Investment Conference at 5:45 p.m. EDT on Tuesday, September 14, 2010, at the Palace Hotel in New York, NY.

Dr. Anzalone will be discussing the Company and its increased focus on its nanomedicine portfolio, including clinical results.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback